Teva Pharmaceutical Industries Ltd.
Teva's Developed G-CSF is the First Biosimilar to Receive a Positive Opinion from European Union Regulators
Published in Blood Weekly, March 6th, 2008
The European Commission is now expected to grant marketing authorization for this product, which will be marketed in the EU by Teva under the brand name TevaGrastim(R).
G-CSF, mainly indicated for the treatment of chemotherapy-induced neutropenia, was developed by Teva in collaboration with a partner. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-03-06)
More Articles from Blood Weekly
- Acidosis
Research in the area of acidosis reported from Maulana Azad Medical College, Medical College - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley
Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation - Breast Cancer
Abviva Announces Patent Issuance for Core Technology Used in Mammastatin Serum Assay Diagnostic Test for Breast Cancer - Cancer
Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers - Dengue Fever
Reports outline dengue fever study findings from M.T. Cordeiro and colleagues - Dengue Fever
Studies from University of Rochester yield new information about dengue fever - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
